SHIP is a negative regulator of growth factor receptor-mediated PKB/Akt activation and myeloid cell survival

  1. Qiurong Liu,
  2. Takehiko Sasaki,
  3. Ivona Kozieradzki,
  4. Andrew Wakeham,
  5. Annick Itie,
  6. Daniel J. Dumont, and
  7. Josef M. Penninger
  1. Amgen Institute, Toronto, Ontario, Canada M5G 2C1; Departments of Immunology, and Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada M5G 2C1; Sunnybrook Hospital and Women’s College Health Science Center, Toronto, Canada, M4N 3M5

Abstract

SHIP is an inositol 5′ phosphatase that hydrolyzes the PI3′K product PI(3,4,5)P3. We show that SHIP-deficient mice exhibit dramatic chronic hyperplasia of myeloid cells resulting in splenomegaly, lymphadenopathy, and myeloid infiltration of vital organs. Neutrophils and bone marrow-derived mast cells from SHIP−/− mice are less susceptible to programmed cell death induced by various apoptotic stimuli or by growth factor withdrawal. Engagement of IL3-R and GM–CSF-R in these cells leads to increased and prolonged PI3′K-dependent PI(3,4,5)P3 accumulation and PKB activation. These data indicate that SHIP is a negative regulator of growth factor-mediated PKB activation and myeloid cell survival.

Keywords

Footnotes

  • Corresponding author.

  • E-MAIL Jpenning{at}amgen.com; FAX (416) 204-2278.

    • Received December 4, 1998.
    • Accepted February 3, 1999.
| Table of Contents

Life Science Alliance